Helixmith Co. Ltd (084990) - Total Assets
Based on the latest financial reports, Helixmith Co. Ltd (084990) holds total assets worth ₩143.20 Billion KRW (≈ $97.04 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Helixmith Co. Ltd shareholders equity for net asset value and shareholders' equity analysis.
Helixmith Co. Ltd - Total Assets Trend (2010–2025)
This chart illustrates how Helixmith Co. Ltd's total assets have evolved over time, based on quarterly financial data.
Helixmith Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Helixmith Co. Ltd's total assets of ₩143.20 Billion consist of 58.5% current assets and 41.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 22.2% |
| Accounts Receivable | ₩181.81 Million | 0.1% |
| Inventory | ₩1.22 Billion | 0.9% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩99.45 Million | 0.1% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2010–2025)
This chart illustrates how Helixmith Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Helixmith Co. Ltd (084990) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Helixmith Co. Ltd's current assets represent 58.5% of total assets in 2025, an increase from 34.5% in 2010.
- Cash Position: Cash and equivalents constituted 22.2% of total assets in 2025, up from 1.0% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 59.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 0.9% of total assets.
Helixmith Co. Ltd Competitors by Total Assets
Key competitors of Helixmith Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
KC Feed Co. Ltd
KQ:025880
|
Korea | ₩120.18 Billion |
|
Inti Kapuas Arowana Tbk
JK:IIKP
|
Indonesia | Rp187.40 Billion |
|
Beeio Honey Ltd
TA:WTS
|
Israel | ILA1.87 Million |
|
MSC Co. Ltd
KQ:009780
|
Korea | ₩269.90 Billion |
|
FarmStory Co. Ltd
KQ:027710
|
Korea | ₩966.09 Billion |
|
Fantasy Network Ltd
TA:FNTS
|
Israel | ILA8.54 Million |
|
Douzone Bizon Co Ltd
KO:012510
|
Korea | ₩1.07 Trillion |
|
Ecopro BM. Co. Ltd
KQ:247540
|
Korea | ₩4.62 Trillion |
Helixmith Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 104.72 | 12.49 | 2.47 |
| Quick Ratio | 103.20 | 12.36 | 2.45 |
| Cash Ratio | 0.00 | 5.72 | 0.00 |
| Working Capital | ₩82.91 Billion | ₩73.94 Billion | ₩165.01 Billion |
Helixmith Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Helixmith Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.88 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -3.8% |
| Total Assets | ₩143.20 Billion |
| Market Capitalization | $93.21 Million USD |
Valuation Analysis
Below Book Valuation: The market values Helixmith Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Helixmith Co. Ltd's assets decreased by 3.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Helixmith Co. Ltd (2010–2025)
The table below shows the annual total assets of Helixmith Co. Ltd from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩143.20 Billion ≈ $97.04 Million |
-3.82% |
| 2024-12-31 | ₩148.89 Billion ≈ $100.90 Million |
-34.49% |
| 2023-12-31 | ₩227.28 Billion ≈ $154.02 Million |
-10.54% |
| 2022-12-31 | ₩254.06 Billion ≈ $172.17 Million |
-10.07% |
| 2021-12-31 | ₩282.50 Billion ≈ $191.45 Million |
-40.92% |
| 2020-12-31 | ₩478.14 Billion ≈ $324.03 Million |
+28.73% |
| 2019-12-31 | ₩371.44 Billion ≈ $251.72 Million |
+30.68% |
| 2018-12-31 | ₩284.24 Billion ≈ $192.62 Million |
+58.45% |
| 2017-12-31 | ₩179.38 Billion ≈ $121.57 Million |
+0.76% |
| 2016-12-31 | ₩178.04 Billion ≈ $120.65 Million |
+152.14% |
| 2015-12-31 | ₩70.61 Billion ≈ $47.85 Million |
+1.41% |
| 2013-12-31 | ₩69.62 Billion ≈ $47.18 Million |
+2.40% |
| 2012-12-31 | ₩67.99 Billion ≈ $46.08 Million |
+13.06% |
| 2011-12-31 | ₩60.14 Billion ≈ $40.75 Million |
-13.60% |
| 2010-12-31 | ₩69.60 Billion ≈ $47.17 Million |
-- |
About Helixmith Co. Ltd
Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological… Read more